No Data
No Data
J&J, Roche Come Out on Top in S&P Ratings of Strongest Pharma Companies
Regeneron Pharmaceuticals' (NASDAQ:REGN) Five-year Earnings Growth Trails the Incredible Shareholder Returns
Catalyst Watch: Eyes on Jackson Hole, Target Earnings, and Canadian Rails Disruption
Form 144 | Regeneron Pharmaceuticals(REGN.US) Director Proposes to Sell 12.54 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Aug 15, $Regeneron Pharmaceuticals(REGN.US)$ Director Christine Poon intends to sell 10,838 shares of its common stock on Aug 15, with a total market value of approximately $12
Regeneron Pharmaceuticals(REGN.US) Officer Sells US$7.34 Million in Common Stock
Alvotech's Biosimilar to Regeneron's Eylea Under EU Review
No Data